miR-873-5p can affect the occurrence and development of cancer by participating in the PIK3/AKT/mTOR, Wnt/β-Catenin, NF-κβ, MEK/ERK, and other signaling pathways (Figure 3). This evidence concerns the gene MAP2K7 and cancer.